This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Trevor E Swartz: Innovator in Antibody Selection Technologies
Introduction
Trevor E Swartz is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods and apparatus for antibody selection. With a total of 2 patents, his work has the potential to impact various applications in medical and pharmaceutical research.
Latest Patents
Trevor's latest patents focus on innovative technologies for antibody selection. One of his patents describes an "Antibody selection apparatus and methods," which includes apparatus, systems, computer-readable media, articles of manufacture, and methods for selecting an antibody. This invention emphasizes the importance of determining one or more physiochemical characteristics of the antibody, based on antibody structural parameters. The second patent reiterates similar methodologies, showcasing his commitment to advancing antibody selection technologies.
Career Highlights
Throughout his career, Trevor has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in antibody development.
Collaborations
Some of Trevor's notable coworkers include Vikas K Sharma and Thomas W Patapoff. Their collaborative efforts have likely played a role in enhancing the quality and impact of his inventions.
Conclusion
Trevor E Swartz is a distinguished inventor whose work in antibody selection technologies is paving the way for advancements in biotechnology. His patents reflect a deep understanding of the complexities involved in antibody development, and his career highlights demonstrate his commitment to innovation in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
